@fordham1

Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

, , , , , , , , , , , , , , , , , , , , , and . Clinical Pharmacology and Therapeutics, (2020)
DOI: 10.1002/cpt.1909

Description

Citation for: ARSHAD et al.

Links and resources

Tags